Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001846099-23-000001
Filing Date
2023-11-14
Accepted
2023-11-14 17:00:17
Documents
1
Effectiveness Date
2023-11-14
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 13520
  Complete submission text file 0001846099-23-000001.txt   14572
Mailing Address 501 LOCUST AVENUE, SUITE 301 CHARLOTTESVILLE VA 22902
Business Address 501 LOCUST AVENUE, SUITE 301 CHARLOTTESVILLE VA 22902 434 872-0196
HEMOSHEAR THERAPEUTICS, INC. (Filer) CIK: 0001846099 (see all company filings)

EIN.: 861288232 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-497215 | Film No.: 231407663